Literature DB >> 19190150

Telomere length, current perceived stress, and urinary stress hormones in women.

Christine G Parks1, Diane B Miller, Erin C McCanlies, Richard M Cawthon, Michael E Andrew, Lisa A DeRoo, Dale P Sandler.   

Abstract

Telomeres are repetitive DNA sequences that cap and protect the ends of chromosomes; critically short telomeres may lead to cellular senescence or carcinogenic transformation. Previous findings suggest a link between psychosocial stress, shorter telomeres, and chronic disease risk. This cross-sectional study examined relative telomere length in relation to perceived stress and urinary stress hormones in a sample of participants (n = 647) in the National Institute of Environmental Health Sciences Sister Study, a cohort of women ages 35 to 74 years who have a sister with breast cancer. Average leukocyte telomere length was determined by quantitative PCR. Current stress was assessed using the Perceived Stress Scale and creatinine-adjusted neuroendocrine hormones in first morning urines. Linear regression models estimated differences in telomere length base pairs (bp) associated with stress measures adjusted for age, race, smoking, and obesity. Women with higher perceived stress had somewhat shorter telomeres [adjusted difference of -129bp for being at or above moderate stress levels; 95% confidence interval (CI), -292 to 33], but telomere length did not decrease monotonically with higher stress levels. Shorter telomeres were independently associated with increasing age (-27bp/year), obesity, and current smoking. Significant stress-related differences in telomere length were seen in women ages 55 years and older (-289bp; 95% CI, -519 to -59), those with recent major losses (-420bp; 95% CI, -814 to -27), and those with above-average urinary catecholamines (e.g., epinephrine: -484bp; 95% CI, -709 to -259). Although current perceived stress was only modestly associated with shorter telomeres in this broad sample of women, our findings suggest the effect of stress on telomere length may vary depending on neuroendocrine responsiveness, external stressors, and age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190150      PMCID: PMC2696885          DOI: 10.1158/1055-9965.EPI-08-0614

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  39 in total

Review 1.  Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load.

Authors:  Bruce S McEwen
Journal:  Metabolism       Date:  2006-10       Impact factor: 8.694

Review 2.  A new view on hypocortisolism.

Authors:  Eva Fries; Judith Hesse; Juliane Hellhammer; Dirk H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  2005-11       Impact factor: 4.905

3.  The effects of social status on biological aging as measured by white-blood-cell telomere length.

Authors:  L F Cherkas; A Aviv; A M Valdes; J L Hunkin; J P Gardner; G L Surdulescu; M Kimura; T D Spector
Journal:  Aging Cell       Date:  2006-10       Impact factor: 9.304

4.  Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study.

Authors:  Scott W Brouilette; Jasbir S Moore; Alex D McMahon; John R Thompson; Ian Ford; James Shepherd; Chris J Packard; Nilesh J Samani
Journal:  Lancet       Date:  2007-01-13       Impact factor: 79.321

5.  Cell aging in relation to stress arousal and cardiovascular disease risk factors.

Authors:  Elissa S Epel; Jue Lin; Frank H Wilhelm; Owen M Wolkowitz; Richard Cawthon; Nancy E Adler; Christyn Dolbier; Wendy B Mendes; Elizabeth H Blackburn
Journal:  Psychoneuroendocrinology       Date:  2005-11-17       Impact factor: 4.905

Review 6.  Human telomere biology: pitfalls of moving from the laboratory to epidemiology.

Authors:  Abraham Aviv; Ana M Valdes; Tim D Spector
Journal:  Int J Epidemiol       Date:  2006-09-22       Impact factor: 7.196

7.  Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.

Authors:  Uri Tabori; Sonia Nanda; Harriet Druker; Jodi Lees; David Malkin
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Genetic pathway of major depressive disorder in shortening telomeric length.

Authors:  For-Wey Lung; Nathan C Chen; Bih-Ching Shu
Journal:  Psychiatr Genet       Date:  2007-06       Impact factor: 2.458

9.  Telomere length, cigarette smoking, and bladder cancer risk in men and women.

Authors:  Monica McGrath; Jason Y Y Wong; Dominique Michaud; David J Hunter; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-04       Impact factor: 4.254

10.  The relationship between smoking status and cortisol secretion.

Authors:  Ellena Badrick; Clemens Kirschbaum; Meena Kumari
Journal:  J Clin Endocrinol Metab       Date:  2006-12-19       Impact factor: 5.958

View more
  80 in total

1.  Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study.

Authors:  Jennifer Daubenmier; Jue Lin; Elizabeth Blackburn; Frederick M Hecht; Jean Kristeller; Nicole Maninger; Margaret Kuwata; Peter Bacchetti; Peter J Havel; Elissa Epel
Journal:  Psychoneuroendocrinology       Date:  2011-12-14       Impact factor: 4.905

2.  Does cellular aging relate to patterns of allostasis? An examination of basal and stress reactive HPA axis activity and telomere length.

Authors:  A Janet Tomiyama; Aoife O'Donovan; Jue Lin; Eli Puterman; Alanie Lazaro; Jessica Chan; Firdaus S Dhabhar; Owen Wolkowitz; Clemens Kirschbaum; Elizabeth Blackburn; Elissa Epel
Journal:  Physiol Behav       Date:  2011-11-28

Review 3.  Telomeres, early-life stress and mental illness.

Authors:  Samuel J Ridout; Kathryn K Ridout; Hung-Teh Kao; Linda L Carpenter; Noah S Philip; Audrey R Tyrka; Lawrence H Price
Journal:  Adv Psychosom Med       Date:  2015-03-30

Review 4.  An integrative review of factors associated with telomere length and implications for biobehavioral research.

Authors:  Angela R Starkweather; Areej A Alhaeeri; Alison Montpetit; Jenni Brumelle; Kristin Filler; Marty Montpetit; Lathika Mohanraj; Debra E Lyon; Colleen K Jackson-Cook
Journal:  Nurs Res       Date:  2014 Jan-Feb       Impact factor: 2.381

5.  Telomere length is inversely correlated with urinary stress hormone levels in healthy controls but not in un-medicated depressed individuals-preliminary findings.

Authors:  Brittany Fair; Synthia H Mellon; Elissa S Epel; Jue Lin; Dóra Révész; Josine E Verhoeven; Brenda W Penninx; Victor I Reus; Rebecca Rosser; Christina M Hough; Laura Mahan; Heather M Burke; Elizabeth H Blackburn; Owen M Wolkowitz
Journal:  J Psychosom Res       Date:  2017-06-15       Impact factor: 3.006

6.  Discrimination and Telomere Length Among Older Adults in the United States.

Authors:  Sze Yan Liu; Ichiro Kawachi
Journal:  Public Health Rep       Date:  2017-02-01       Impact factor: 2.792

Review 7.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Authors:  Jennifer Prescott; Ingrid M Wentzensen; Sharon A Savage; Immaculata De Vivo
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

8.  Dynamics of telomerase activity in response to acute psychological stress.

Authors:  Elissa S Epel; Jue Lin; Firdaus S Dhabhar; Owen M Wolkowitz; E Puterman; Lori Karan; Elizabeth H Blackburn
Journal:  Brain Behav Immun       Date:  2009-12-16       Impact factor: 7.217

9.  Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.

Authors:  Debra Lyon; Lynne Elmore; Noran Aboalela; Jacqueline Merrill-Schools; Nancy McCain; Angela Starkweather; R K Elswick; Colleen Jackson-Cook
Journal:  Biol Res Nurs       Date:  2013-04-11       Impact factor: 2.522

Review 10.  Black sheep get the blues: a psychobiological model of social rejection and depression.

Authors:  George M Slavich; Aoife O'Donovan; Elissa S Epel; Margaret E Kemeny
Journal:  Neurosci Biobehav Rev       Date:  2010-01-18       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.